Preparation and in vivo anti-tumor evaluation of human papillomavirus E7 adjuvanted with Montanide ISA 266 as a vaccine candidate

Preparation and in vivo anti-tumor evaluation of human papillomavirus E7 adjuvanted with Montanide ISA 266 as a vaccine candidate

Introduction: Human papillomavirus (HPV) 16 E7 protein is expressed constitutively by HPV-infected tumor cells. Mutant versions of E7 are considered as safer candidates for immunotherapy of cervical cancer.  Different strategies including formulation with adjuvants are used to induce a potent immune...

Full description

Bibliographic Details
Main Authors: M Mashhadi Abolghasem Shirazi, F Roohvand, A Arashkia
Format: Article
Language:English
Published: Pasteur Institute of Iran 2017-05-01
Series:Vaccine Research
Subjects:
human papillomavirus 16
e7 oncogene
protein vaccine.
Online Access:http://vacres.pasteur.ac.ir/article-1-105-en.html

Internet

http://vacres.pasteur.ac.ir/article-1-105-en.html

Similar Items